動物用感染症診断薬の市場規模、シェア、成長分析：感染タイプ別、技術別、動物タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

動物用感染症診断薬市場規模は2023年に20億米ドルと評価され、2024年の21億8,000万米ドルから2032年には43億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.0％で成長する見通しです。

動物用感染症診断薬市場は、動物の感染症を迅速かつ正確に特定するために不可欠であり、健康状態の改善と疾病管理の向上につながります。世界化、気候変動、進化する飼育方法などの影響を受けて、動物感染症が増加しており、市場の成長を後押ししています。しかし、診断コストの高さ、発展途上地域でのアクセス制限、熟練した専門家の不足といった課題は、市場拡大の妨げになる可能性があります。高感度で特異的な診断ツールを開発するためには、継続的な研究開発が不可欠です。このような障害にもかかわらず、迅速検査やポイント・オブ・ケア検査などの技術革新による機会は豊富にあります。人獣共通感染症およびワンヘルスパラダイムに対する意識の高まりがこの市場をさらに後押しし、世界の動物および公衆衛生管理における重要な役割を確固たるものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

動物用感染症診断薬市場規模：感染タイプ別& CAGR（2025-2032）

• 市場概要
• 細菌感染症
• ウイルス感染
• 寄生虫感染症
• その他の感染症

動物用感染症診断薬市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 免疫診断
  • ラテラルフローアッセイ
  • ELISA検査
• その他の免疫診断技術
• 分子診断
  • ポリメラーゼ連鎖反応（PCR）検査
  • マイクロアレイ
• その他の分子診断検査
• その他の獣医診断技術

動物用感染症診断薬市場規模：動物タイプ別& CAGR（2025-2032）

• 市場概要
• コンパニオンアニマル
  • 犬
  • 猫
  • 馬
• その他のペット
• 食用動物
  • 牛
  • 豚
  • 家禽
  • その他の食用動物

動物用感染症診断薬市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• リファレンスラボ
• 獣医学研究所・診療所
• ポイントオブケア・社内検査
• 調査機関・大学

動物用感染症診断薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• IDEXX Laboratories, Inc.（US）
• Zoetis, Inc.（US）
• Thermo Fisher Scientific, Inc.（US）
• Virbac（France）
• bioMerieux SA（France）
• Heska Corporation（US）
• NEOGEN Corporation（US）
• QIAGEN N.V.（Netherlands）
• Randox Laboratories Ltd.（UK）
• Agrolabo S.pA.（Italy）
• Bio-Rad Laboratories（US）
• Bionote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electric Co. Ltd.（China）
• MEGACOR Diagnostik GmbH（Germany）
• Fassisi GmbH（Germany）
• Alvedia（France）
• SKYER, Inc.（South Korea）

結論と推奨事項

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.18 billion in 2024 to USD 4.34 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The veterinary infectious disease diagnostics market is essential for the prompt and accurate identification of infectious diseases in animals, leading to enhanced health outcomes and improved disease control. Rising instances of animal infectious diseases, influenced by globalization, climate change, and evolving husbandry practices, are fueling market growth. However, challenges like high diagnostic costs, limited accessibility in developing regions, and a shortage of skilled professionals may hinder its expansion. Continuous R&D is crucial to develop sensitive and specific diagnostic tools. Despite these barriers, opportunities abound through technological innovations, such as rapid and point-of-care tests. Increased awareness of zoonotic diseases and the One Health paradigm further propels this market, solidifying its critical role in global animal and public health management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and Region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The veterinary infectious disease diagnostics market is witnessing significant growth driven by heightened awareness of animal health and welfare among pet owners and livestock producers. There is a burgeoning demand for sophisticated diagnostic tools and services that facilitate the early detection and effective management of infectious diseases. The COVID-19 pandemic in 2022 underscored the critical need for monitoring animal health and establishing strong diagnostic systems to identify potential zoonotic diseases, further emphasizing the importance of investing in advanced veterinary diagnostics. This increased focus on animal welfare and disease prevention has propelled the market forward, creating a need for innovative solutions in this sector.

Restraints in the Veterinary Infectious Disease Diagnostics Market

One major constraint in the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. Implementing state-of-the-art diagnostic tools often demands considerable financial investment, which can be particularly challenging for small veterinary practices or those situated in financially limited areas. This financial barrier may restrict the accessibility and application of sophisticated diagnostic techniques, ultimately restraining the overall growth of the market. As a result, the disparity in resources can lead to uneven adoption rates of these innovative technologies, impacting the efficiency of disease diagnosis and management in the veterinary field.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is increasingly influenced by the growing adoption of point-of-care testing (POCT), which has emerged as a pivotal trend. With the shift towards rapid, on-site diagnostic capabilities, veterinarians can now obtain real-time results without relying on centralized laboratories, thereby enhancing immediate decision-making and operational efficiency. This trend has accelerated since 2022, driven by advancements in portable and user-friendly POCT devices tailored for infectious disease diagnosis in animals. As the demand for timely and accurate diagnostics rises, the market is poised for significant growth, reflecting a broader commitment to improving animal health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2025-2032)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations